magnetic selection kit Search Results


90
STEMCELL Technologies Inc cd8 magnetic selection kit
Cd8 Magnetic Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/magnetic+selection+kit/magnetic+beads+cd8+negative+selection+kit/pm28198370-327-30-34
Average 90 stars, based on 1 article reviews
cd8 magnetic selection kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc antibody-coated magnetic beads easysep human cd4 positive selection
Antibody Coated Magnetic Beads Easysep Human Cd4 Positive Selection, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/magnetic+selection+kit/easysep+release+apc+positive+magnetic+selection+kit/pmc07317241-123-12-19
Average 90 stars, based on 1 article reviews
antibody-coated magnetic beads easysep human cd4 positive selection - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc magnetic bead-based positive selection kit
Magnetic Bead Based Positive Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/magnetic+selection+kit/magnetic+negative+selection+kit/pm33804564-46-9-11
Average 90 stars, based on 1 article reviews
magnetic bead-based positive selection kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc ly-6g

Ly 6g, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/magnetic+selection+kit/easysep+pe+anti+ly+6g+magnetic+selection+kit/pmc10187541-354-9-13
Average 90 stars, based on 1 article reviews
ly-6g - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc cd8 + t-cell positive magnetic selection kit ii
Hepatitis C virus (HCV) core protein reduces <t>CD8+</t> T‐cell proliferation and viability. (a) A scatter plot graph shows the proliferation of CFSE‐labelled CD8+ T‐cells cultured alone (Medium) or pre‐incubated with HCV core for increasing periods of time (0, 24, 48 and 72 hr) followed by a 5‐day stimulation with anti‐CD3/CD28 (n = 3, repeated measures analysis of variance with Bonferroni's multiple comparison test). *P < .05, **P < 0·01. (b) A second scatter plot graph indicates the viability of stimulated CD8+ T‐cells incubated with HCV core in a time–course experiment, as determined in studies using phytohaemagglutinin as a stimulant (n = 4; relative change in MTT absorbance). To confirm effects on proliferation, CFSE‐labelled CD8+ T‐cells were pre‐incubated with or without HCV core (5 µg/ml) for 72 hr followed by 5 days of stimulation with anti‐CD3/28 (0·0625 µg/ml). (c) A representative histogram shows the proliferation profile of CFSE‐labelled CD8+ T‐cells. The marker indicates the decreasing fluorescence intensity traces of proliferating (i.e. CFSE low) cells. (d) A scatter plot summarizes the proliferation of CD8+ T‐cells pre‐incubated with medium or HCV core for 72 hr followed by stimulation with anti‐CD3/28 for 72 hr (mean ± SD, two‐tailed paired Student's t‐test, n = 5).
Cd8 + T Cell Positive Magnetic Selection Kit Ii, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/magnetic+selection+kit/cd8+++t+cell+positive+magnetic+selection+kit+ii/pmc05904700-70-34-44
Average 90 stars, based on 1 article reviews
cd8 + t-cell positive magnetic selection kit ii - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc negative selection easysep magnet human neutrophil enrichment kit
Hepatitis C virus (HCV) core protein reduces <t>CD8+</t> T‐cell proliferation and viability. (a) A scatter plot graph shows the proliferation of CFSE‐labelled CD8+ T‐cells cultured alone (Medium) or pre‐incubated with HCV core for increasing periods of time (0, 24, 48 and 72 hr) followed by a 5‐day stimulation with anti‐CD3/CD28 (n = 3, repeated measures analysis of variance with Bonferroni's multiple comparison test). *P < .05, **P < 0·01. (b) A second scatter plot graph indicates the viability of stimulated CD8+ T‐cells incubated with HCV core in a time–course experiment, as determined in studies using phytohaemagglutinin as a stimulant (n = 4; relative change in MTT absorbance). To confirm effects on proliferation, CFSE‐labelled CD8+ T‐cells were pre‐incubated with or without HCV core (5 µg/ml) for 72 hr followed by 5 days of stimulation with anti‐CD3/28 (0·0625 µg/ml). (c) A representative histogram shows the proliferation profile of CFSE‐labelled CD8+ T‐cells. The marker indicates the decreasing fluorescence intensity traces of proliferating (i.e. CFSE low) cells. (d) A scatter plot summarizes the proliferation of CD8+ T‐cells pre‐incubated with medium or HCV core for 72 hr followed by stimulation with anti‐CD3/28 for 72 hr (mean ± SD, two‐tailed paired Student's t‐test, n = 5).
Negative Selection Easysep Magnet Human Neutrophil Enrichment Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/magnetic+selection+kit/negative+selection+easysep+magnet+human+neutrophil+enrichment+kit/pmc06630776-150-14-21
Average 90 stars, based on 1 article reviews
negative selection easysep magnet human neutrophil enrichment kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc cd4+ selection magnetic beads
Hepatitis C virus (HCV) core protein reduces <t>CD8+</t> T‐cell proliferation and viability. (a) A scatter plot graph shows the proliferation of CFSE‐labelled CD8+ T‐cells cultured alone (Medium) or pre‐incubated with HCV core for increasing periods of time (0, 24, 48 and 72 hr) followed by a 5‐day stimulation with anti‐CD3/CD28 (n = 3, repeated measures analysis of variance with Bonferroni's multiple comparison test). *P < .05, **P < 0·01. (b) A second scatter plot graph indicates the viability of stimulated CD8+ T‐cells incubated with HCV core in a time–course experiment, as determined in studies using phytohaemagglutinin as a stimulant (n = 4; relative change in MTT absorbance). To confirm effects on proliferation, CFSE‐labelled CD8+ T‐cells were pre‐incubated with or without HCV core (5 µg/ml) for 72 hr followed by 5 days of stimulation with anti‐CD3/28 (0·0625 µg/ml). (c) A representative histogram shows the proliferation profile of CFSE‐labelled CD8+ T‐cells. The marker indicates the decreasing fluorescence intensity traces of proliferating (i.e. CFSE low) cells. (d) A scatter plot summarizes the proliferation of CD8+ T‐cells pre‐incubated with medium or HCV core for 72 hr followed by stimulation with anti‐CD3/28 for 72 hr (mean ± SD, two‐tailed paired Student's t‐test, n = 5).
Cd4+ Selection Magnetic Beads, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/magnetic+selection+kit/negative+cd4+magnetic+selection+kit/10__1189_slash_jlb__4a0915___422r-66-23-27
Average 90 stars, based on 1 article reviews
cd4+ selection magnetic beads - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc magnetic beads-based positive selection
Hepatitis C virus (HCV) core protein reduces <t>CD8+</t> T‐cell proliferation and viability. (a) A scatter plot graph shows the proliferation of CFSE‐labelled CD8+ T‐cells cultured alone (Medium) or pre‐incubated with HCV core for increasing periods of time (0, 24, 48 and 72 hr) followed by a 5‐day stimulation with anti‐CD3/CD28 (n = 3, repeated measures analysis of variance with Bonferroni's multiple comparison test). *P < .05, **P < 0·01. (b) A second scatter plot graph indicates the viability of stimulated CD8+ T‐cells incubated with HCV core in a time–course experiment, as determined in studies using phytohaemagglutinin as a stimulant (n = 4; relative change in MTT absorbance). To confirm effects on proliferation, CFSE‐labelled CD8+ T‐cells were pre‐incubated with or without HCV core (5 µg/ml) for 72 hr followed by 5 days of stimulation with anti‐CD3/28 (0·0625 µg/ml). (c) A representative histogram shows the proliferation profile of CFSE‐labelled CD8+ T‐cells. The marker indicates the decreasing fluorescence intensity traces of proliferating (i.e. CFSE low) cells. (d) A scatter plot summarizes the proliferation of CD8+ T‐cells pre‐incubated with medium or HCV core for 72 hr followed by stimulation with anti‐CD3/28 for 72 hr (mean ± SD, two‐tailed paired Student's t‐test, n = 5).
Magnetic Beads Based Positive Selection, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/magnetic+selection+kit/magnetic+bead+selection+kit/pm38206120-43-17-18
Average 90 stars, based on 1 article reviews
magnetic beads-based positive selection - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc cd271positive selection kit with magnetic nanoparticles
Hepatitis C virus (HCV) core protein reduces <t>CD8+</t> T‐cell proliferation and viability. (a) A scatter plot graph shows the proliferation of CFSE‐labelled CD8+ T‐cells cultured alone (Medium) or pre‐incubated with HCV core for increasing periods of time (0, 24, 48 and 72 hr) followed by a 5‐day stimulation with anti‐CD3/CD28 (n = 3, repeated measures analysis of variance with Bonferroni's multiple comparison test). *P < .05, **P < 0·01. (b) A second scatter plot graph indicates the viability of stimulated CD8+ T‐cells incubated with HCV core in a time–course experiment, as determined in studies using phytohaemagglutinin as a stimulant (n = 4; relative change in MTT absorbance). To confirm effects on proliferation, CFSE‐labelled CD8+ T‐cells were pre‐incubated with or without HCV core (5 µg/ml) for 72 hr followed by 5 days of stimulation with anti‐CD3/28 (0·0625 µg/ml). (c) A representative histogram shows the proliferation profile of CFSE‐labelled CD8+ T‐cells. The marker indicates the decreasing fluorescence intensity traces of proliferating (i.e. CFSE low) cells. (d) A scatter plot summarizes the proliferation of CD8+ T‐cells pre‐incubated with medium or HCV core for 72 hr followed by stimulation with anti‐CD3/28 for 72 hr (mean ± SD, two‐tailed paired Student's t‐test, n = 5).
Cd271positive Selection Kit With Magnetic Nanoparticles, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/magnetic+selection+kit/cd271positive+selection+kit+with+magnetic+nanoparticles/pm24831840-45-26-28
Average 90 stars, based on 1 article reviews
cd271positive selection kit with magnetic nanoparticles - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc human-specific, magnetic, bead-based, negative selection kit
Hepatitis C virus (HCV) core protein reduces <t>CD8+</t> T‐cell proliferation and viability. (a) A scatter plot graph shows the proliferation of CFSE‐labelled CD8+ T‐cells cultured alone (Medium) or pre‐incubated with HCV core for increasing periods of time (0, 24, 48 and 72 hr) followed by a 5‐day stimulation with anti‐CD3/CD28 (n = 3, repeated measures analysis of variance with Bonferroni's multiple comparison test). *P < .05, **P < 0·01. (b) A second scatter plot graph indicates the viability of stimulated CD8+ T‐cells incubated with HCV core in a time–course experiment, as determined in studies using phytohaemagglutinin as a stimulant (n = 4; relative change in MTT absorbance). To confirm effects on proliferation, CFSE‐labelled CD8+ T‐cells were pre‐incubated with or without HCV core (5 µg/ml) for 72 hr followed by 5 days of stimulation with anti‐CD3/28 (0·0625 µg/ml). (c) A representative histogram shows the proliferation profile of CFSE‐labelled CD8+ T‐cells. The marker indicates the decreasing fluorescence intensity traces of proliferating (i.e. CFSE low) cells. (d) A scatter plot summarizes the proliferation of CD8+ T‐cells pre‐incubated with medium or HCV core for 72 hr followed by stimulation with anti‐CD3/28 for 72 hr (mean ± SD, two‐tailed paired Student's t‐test, n = 5).
Human Specific, Magnetic, Bead Based, Negative Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/magnetic+selection+kit/human+specific++magnetic++bead+based++negative+selection+kit/pmc08418256-118-11-14
Average 90 stars, based on 1 article reviews
human-specific, magnetic, bead-based, negative selection kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc negative selection magnetic separation kit 19054
Hepatitis C virus (HCV) core protein reduces <t>CD8+</t> T‐cell proliferation and viability. (a) A scatter plot graph shows the proliferation of CFSE‐labelled CD8+ T‐cells cultured alone (Medium) or pre‐incubated with HCV core for increasing periods of time (0, 24, 48 and 72 hr) followed by a 5‐day stimulation with anti‐CD3/CD28 (n = 3, repeated measures analysis of variance with Bonferroni's multiple comparison test). *P < .05, **P < 0·01. (b) A second scatter plot graph indicates the viability of stimulated CD8+ T‐cells incubated with HCV core in a time–course experiment, as determined in studies using phytohaemagglutinin as a stimulant (n = 4; relative change in MTT absorbance). To confirm effects on proliferation, CFSE‐labelled CD8+ T‐cells were pre‐incubated with or without HCV core (5 µg/ml) for 72 hr followed by 5 days of stimulation with anti‐CD3/28 (0·0625 µg/ml). (c) A representative histogram shows the proliferation profile of CFSE‐labelled CD8+ T‐cells. The marker indicates the decreasing fluorescence intensity traces of proliferating (i.e. CFSE low) cells. (d) A scatter plot summarizes the proliferation of CD8+ T‐cells pre‐incubated with medium or HCV core for 72 hr followed by stimulation with anti‐CD3/28 for 72 hr (mean ± SD, two‐tailed paired Student's t‐test, n = 5).
Negative Selection Magnetic Separation Kit 19054, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/magnetic+selection+kit/negative+selection+magnetic+separation+kit+19054/pmc07010227-156-11-16
Average 90 stars, based on 1 article reviews
negative selection magnetic separation kit 19054 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc magnetic-bead based positive selection kit with a biotynylated c-kit primary antibody easysep positive biotin selection kit
Hepatitis C virus (HCV) core protein reduces <t>CD8+</t> T‐cell proliferation and viability. (a) A scatter plot graph shows the proliferation of CFSE‐labelled CD8+ T‐cells cultured alone (Medium) or pre‐incubated with HCV core for increasing periods of time (0, 24, 48 and 72 hr) followed by a 5‐day stimulation with anti‐CD3/CD28 (n = 3, repeated measures analysis of variance with Bonferroni's multiple comparison test). *P < .05, **P < 0·01. (b) A second scatter plot graph indicates the viability of stimulated CD8+ T‐cells incubated with HCV core in a time–course experiment, as determined in studies using phytohaemagglutinin as a stimulant (n = 4; relative change in MTT absorbance). To confirm effects on proliferation, CFSE‐labelled CD8+ T‐cells were pre‐incubated with or without HCV core (5 µg/ml) for 72 hr followed by 5 days of stimulation with anti‐CD3/28 (0·0625 µg/ml). (c) A representative histogram shows the proliferation profile of CFSE‐labelled CD8+ T‐cells. The marker indicates the decreasing fluorescence intensity traces of proliferating (i.e. CFSE low) cells. (d) A scatter plot summarizes the proliferation of CD8+ T‐cells pre‐incubated with medium or HCV core for 72 hr followed by stimulation with anti‐CD3/28 for 72 hr (mean ± SD, two‐tailed paired Student's t‐test, n = 5).
Magnetic Bead Based Positive Selection Kit With A Biotynylated C Kit Primary Antibody Easysep Positive Biotin Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/magnetic+selection+kit/magnetic+bead+based+positive+selection+kit+with+a+biotynylated+c+kit+primary+antibody+easysep+positive+biotin+selection+kit/pmc02825759-170-21-29
Average 90 stars, based on 1 article reviews
magnetic-bead based positive selection kit with a biotynylated c-kit primary antibody easysep positive biotin selection kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Journal: Cell reports

Article Title: TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent state

doi: 10.1016/j.celrep.2023.112129

Figure Lengend Snippet:

Article Snippet: The antibodies used were: CD45 (Cat #: MCD4501, Invitrogen); Ly-6G (Cat #: 60031PB.1, StemCell Technologies Inc); Ly6C (Cat #: 17-5932-82, Life Technologies), CD11b (Cat #: 53-0112-82, Life Technologies); F4/80 (Cat #: 17-4801-80, Life Technologies), B220 (Cat #: 17-0452-82, Life Technologies), CD3 (Cat #: 11-0031-82, Life Technologies), CD8 (Cat #: 100712, BioLegend), CD4 (Cat #: 48-0041-82, Life Technologies), NK1.1 (Cat #: 108706, BioLegend), FoxP3 (Cat #: 17-4801-80, Life Technologies).

Techniques: Sequencing, Recombinant, Staining, Enzyme-linked Immunosorbent Assay, Transfection, SYBR Green Assay, Viability Assay, Plasmid Preparation, Bicinchoninic Acid Protein Assay, Derivative Assay, Real-time Polymerase Chain Reaction, Software

Hepatitis C virus (HCV) core protein reduces CD8+ T‐cell proliferation and viability. (a) A scatter plot graph shows the proliferation of CFSE‐labelled CD8+ T‐cells cultured alone (Medium) or pre‐incubated with HCV core for increasing periods of time (0, 24, 48 and 72 hr) followed by a 5‐day stimulation with anti‐CD3/CD28 (n = 3, repeated measures analysis of variance with Bonferroni's multiple comparison test). *P < .05, **P < 0·01. (b) A second scatter plot graph indicates the viability of stimulated CD8+ T‐cells incubated with HCV core in a time–course experiment, as determined in studies using phytohaemagglutinin as a stimulant (n = 4; relative change in MTT absorbance). To confirm effects on proliferation, CFSE‐labelled CD8+ T‐cells were pre‐incubated with or without HCV core (5 µg/ml) for 72 hr followed by 5 days of stimulation with anti‐CD3/28 (0·0625 µg/ml). (c) A representative histogram shows the proliferation profile of CFSE‐labelled CD8+ T‐cells. The marker indicates the decreasing fluorescence intensity traces of proliferating (i.e. CFSE low) cells. (d) A scatter plot summarizes the proliferation of CD8+ T‐cells pre‐incubated with medium or HCV core for 72 hr followed by stimulation with anti‐CD3/28 for 72 hr (mean ± SD, two‐tailed paired Student's t‐test, n = 5).

Journal: Immunology

Article Title: Hepatitis C virus core protein reduces CD 8 + T‐cell proliferation, perforin production and degranulation but increases STAT 5 activation

doi: 10.1111/imm.12882

Figure Lengend Snippet: Hepatitis C virus (HCV) core protein reduces CD8+ T‐cell proliferation and viability. (a) A scatter plot graph shows the proliferation of CFSE‐labelled CD8+ T‐cells cultured alone (Medium) or pre‐incubated with HCV core for increasing periods of time (0, 24, 48 and 72 hr) followed by a 5‐day stimulation with anti‐CD3/CD28 (n = 3, repeated measures analysis of variance with Bonferroni's multiple comparison test). *P < .05, **P < 0·01. (b) A second scatter plot graph indicates the viability of stimulated CD8+ T‐cells incubated with HCV core in a time–course experiment, as determined in studies using phytohaemagglutinin as a stimulant (n = 4; relative change in MTT absorbance). To confirm effects on proliferation, CFSE‐labelled CD8+ T‐cells were pre‐incubated with or without HCV core (5 µg/ml) for 72 hr followed by 5 days of stimulation with anti‐CD3/28 (0·0625 µg/ml). (c) A representative histogram shows the proliferation profile of CFSE‐labelled CD8+ T‐cells. The marker indicates the decreasing fluorescence intensity traces of proliferating (i.e. CFSE low) cells. (d) A scatter plot summarizes the proliferation of CD8+ T‐cells pre‐incubated with medium or HCV core for 72 hr followed by stimulation with anti‐CD3/28 for 72 hr (mean ± SD, two‐tailed paired Student's t‐test, n = 5).

Article Snippet: Cells Human peripheral blood mononuclear cells were isolated from the blood of healthy HCV − donors using Lymphoprep (StemCell Technologies, Vancouver, BC, Canada) density gradient centrifugation, followed by isolation of CD8 + T‐cells using CD8 + T‐cell Positive Magnetic Selection Kit I or II (StemCell Technologies).

Techniques: Virus, Cell Culture, Incubation, Comparison, Marker, Fluorescence, Two Tailed Test

Incubation with hepatitis C virus (HCV) core protein decreases interleukin‐7 (IL‐7) ‐mediated Bcl‐2 production in CD8+ T‐cells. CD8+ T‐cells incubated with or without HCV core protein (5 µg/ml) for 72 hr were treated with IL‐7 (1 ng/ml) for 48 hr. Cells were then stained with anti‐human Bcl‐2 antibody before analysis on a flow cytometer. (a) Representative histograms, with marker indicating Bcl‐2hi cells. (b) Average proportion of Bcl‐2hi cells ± SD (two‐tailed paired Student's t‐test, n = 8).

Journal: Immunology

Article Title: Hepatitis C virus core protein reduces CD 8 + T‐cell proliferation, perforin production and degranulation but increases STAT 5 activation

doi: 10.1111/imm.12882

Figure Lengend Snippet: Incubation with hepatitis C virus (HCV) core protein decreases interleukin‐7 (IL‐7) ‐mediated Bcl‐2 production in CD8+ T‐cells. CD8+ T‐cells incubated with or without HCV core protein (5 µg/ml) for 72 hr were treated with IL‐7 (1 ng/ml) for 48 hr. Cells were then stained with anti‐human Bcl‐2 antibody before analysis on a flow cytometer. (a) Representative histograms, with marker indicating Bcl‐2hi cells. (b) Average proportion of Bcl‐2hi cells ± SD (two‐tailed paired Student's t‐test, n = 8).

Article Snippet: Cells Human peripheral blood mononuclear cells were isolated from the blood of healthy HCV − donors using Lymphoprep (StemCell Technologies, Vancouver, BC, Canada) density gradient centrifugation, followed by isolation of CD8 + T‐cells using CD8 + T‐cell Positive Magnetic Selection Kit I or II (StemCell Technologies).

Techniques: Incubation, Virus, Staining, Flow Cytometry, Marker, Two Tailed Test

Incubation with hepatitis C virus (HCV) core protein increases signal transducer and activator of transcription 5 (STAT5) activation in CD8+ T‐cells. CD8+ T‐cells were incubated with or without HCV core protein (5 µg/ml) for 72 hr before treatment with interleukin‐7 (IL‐7; 1 ng/ml) for 15 min. Cells were then labelled with anti‐pSTAT5 antibody and analysed on a flow cytometer. (a) Representative histogram depicting effect of HCV core on STAT5 activation. (b) Mean MFI ± SD of pSTAT5 production (i.e. activated STAT5; two‐tailed paired Student's t‐test, n = 6).

Journal: Immunology

Article Title: Hepatitis C virus core protein reduces CD 8 + T‐cell proliferation, perforin production and degranulation but increases STAT 5 activation

doi: 10.1111/imm.12882

Figure Lengend Snippet: Incubation with hepatitis C virus (HCV) core protein increases signal transducer and activator of transcription 5 (STAT5) activation in CD8+ T‐cells. CD8+ T‐cells were incubated with or without HCV core protein (5 µg/ml) for 72 hr before treatment with interleukin‐7 (IL‐7; 1 ng/ml) for 15 min. Cells were then labelled with anti‐pSTAT5 antibody and analysed on a flow cytometer. (a) Representative histogram depicting effect of HCV core on STAT5 activation. (b) Mean MFI ± SD of pSTAT5 production (i.e. activated STAT5; two‐tailed paired Student's t‐test, n = 6).

Article Snippet: Cells Human peripheral blood mononuclear cells were isolated from the blood of healthy HCV − donors using Lymphoprep (StemCell Technologies, Vancouver, BC, Canada) density gradient centrifugation, followed by isolation of CD8 + T‐cells using CD8 + T‐cell Positive Magnetic Selection Kit I or II (StemCell Technologies).

Techniques: Incubation, Virus, Activation Assay, Flow Cytometry, Two Tailed Test

Hepatitis C virus (HCV) core protein reduces perforin production of CD8+ T‐cells. CD8+ T‐cells were incubated with or without HCV core protein (5 µg/ml) for 72 hr before stimulation with anti‐CD3/28 (1 µg/ml) for 48 hr, and then labelled with anti‐human perforin antibody and analysed by flow cytometry, or stimulated for a further 72 hr before collection of supernatants for quantification of perforin release. (a) A representative histogram is shown with marker indicating perforin+ cells. (b) Average proportion of perforin+ cells ± SD (two‐tailed paired Student's t‐test, n = 9). (c) Perforin release from stimulated CD8+ T‐cells as measured from supernatants by Milliplex Bead Array (one‐tailed paired Student's t‐test, n = 5). ULOD, upper limit of detection.

Journal: Immunology

Article Title: Hepatitis C virus core protein reduces CD 8 + T‐cell proliferation, perforin production and degranulation but increases STAT 5 activation

doi: 10.1111/imm.12882

Figure Lengend Snippet: Hepatitis C virus (HCV) core protein reduces perforin production of CD8+ T‐cells. CD8+ T‐cells were incubated with or without HCV core protein (5 µg/ml) for 72 hr before stimulation with anti‐CD3/28 (1 µg/ml) for 48 hr, and then labelled with anti‐human perforin antibody and analysed by flow cytometry, or stimulated for a further 72 hr before collection of supernatants for quantification of perforin release. (a) A representative histogram is shown with marker indicating perforin+ cells. (b) Average proportion of perforin+ cells ± SD (two‐tailed paired Student's t‐test, n = 9). (c) Perforin release from stimulated CD8+ T‐cells as measured from supernatants by Milliplex Bead Array (one‐tailed paired Student's t‐test, n = 5). ULOD, upper limit of detection.

Article Snippet: Cells Human peripheral blood mononuclear cells were isolated from the blood of healthy HCV − donors using Lymphoprep (StemCell Technologies, Vancouver, BC, Canada) density gradient centrifugation, followed by isolation of CD8 + T‐cells using CD8 + T‐cell Positive Magnetic Selection Kit I or II (StemCell Technologies).

Techniques: Virus, Incubation, Flow Cytometry, Marker, Two Tailed Test, One-tailed Test

Incubation with hepatitis C virus (HCV) core protein reduces degranulation (as indicated by CD107a expression) of CD8+ T‐cells. CD8+ T‐cells incubated with or without HCV core protein (5 µg/ml) for 72 hr were stimulated with anti‐CD3/28 stimulation (1 µg/ml) for 48 hr before analysis by flow cytometry. For the last 6 hr of stimulation, anti‐human CD107a antibody and BD GolgiPlug (containing monensin) was added. (a) A representative histogram with marker indicating CD107a+ cells. (b) Average proportion of CD107a+ cells ± SD (two‐tailed paired Student's t‐test, n = 5).

Journal: Immunology

Article Title: Hepatitis C virus core protein reduces CD 8 + T‐cell proliferation, perforin production and degranulation but increases STAT 5 activation

doi: 10.1111/imm.12882

Figure Lengend Snippet: Incubation with hepatitis C virus (HCV) core protein reduces degranulation (as indicated by CD107a expression) of CD8+ T‐cells. CD8+ T‐cells incubated with or without HCV core protein (5 µg/ml) for 72 hr were stimulated with anti‐CD3/28 stimulation (1 µg/ml) for 48 hr before analysis by flow cytometry. For the last 6 hr of stimulation, anti‐human CD107a antibody and BD GolgiPlug (containing monensin) was added. (a) A representative histogram with marker indicating CD107a+ cells. (b) Average proportion of CD107a+ cells ± SD (two‐tailed paired Student's t‐test, n = 5).

Article Snippet: Cells Human peripheral blood mononuclear cells were isolated from the blood of healthy HCV − donors using Lymphoprep (StemCell Technologies, Vancouver, BC, Canada) density gradient centrifugation, followed by isolation of CD8 + T‐cells using CD8 + T‐cell Positive Magnetic Selection Kit I or II (StemCell Technologies).

Techniques: Incubation, Virus, Expressing, Flow Cytometry, Marker, Two Tailed Test

Incubation with hepatitis C virus (HCV) core protein does not affect proportion of IFN‐γ + CD8+ T‐cells. CD8+ T‐cells incubated with or without HCV core protein (5 µg/ml) for 72 hr were stimulated with anti‐CD3/28 (1 µg/ml) for 24 hr before labelling with anti‐human interferon‐ γ (IFN ‐ γ) antibody and analysis by flow cytometry. Cells were treated with BD GolgiPlug (containing Brefeldin‐A) for the last 5 hr of stimulation. (a) A representative histogram, with analysis marker indicating IFN‐γ + cells. (b) Average proportion of IFN‐γ + cells ± SD (two‐tailed paired Student's t‐test, n = 7).

Journal: Immunology

Article Title: Hepatitis C virus core protein reduces CD 8 + T‐cell proliferation, perforin production and degranulation but increases STAT 5 activation

doi: 10.1111/imm.12882

Figure Lengend Snippet: Incubation with hepatitis C virus (HCV) core protein does not affect proportion of IFN‐γ + CD8+ T‐cells. CD8+ T‐cells incubated with or without HCV core protein (5 µg/ml) for 72 hr were stimulated with anti‐CD3/28 (1 µg/ml) for 24 hr before labelling with anti‐human interferon‐ γ (IFN ‐ γ) antibody and analysis by flow cytometry. Cells were treated with BD GolgiPlug (containing Brefeldin‐A) for the last 5 hr of stimulation. (a) A representative histogram, with analysis marker indicating IFN‐γ + cells. (b) Average proportion of IFN‐γ + cells ± SD (two‐tailed paired Student's t‐test, n = 7).

Article Snippet: Cells Human peripheral blood mononuclear cells were isolated from the blood of healthy HCV − donors using Lymphoprep (StemCell Technologies, Vancouver, BC, Canada) density gradient centrifugation, followed by isolation of CD8 + T‐cells using CD8 + T‐cell Positive Magnetic Selection Kit I or II (StemCell Technologies).

Techniques: Incubation, Virus, Flow Cytometry, Marker, Two Tailed Test

Cells treated with hepatitis C virus (HCV) ‐infected serum produce less perforin upon stimulation. CD8+ T‐cells were incubated with serum from HCV + or healthy HCV − serum for 72 hr before stimulation with anti‐CD3/28 for 48 hr. Cells were then labelled with anti‐human perforin antibody and analysed by flow cytometry. Average proportion of perforin+ cells ± SD (two‐tailed paired Student's t‐test, n = 6).

Journal: Immunology

Article Title: Hepatitis C virus core protein reduces CD 8 + T‐cell proliferation, perforin production and degranulation but increases STAT 5 activation

doi: 10.1111/imm.12882

Figure Lengend Snippet: Cells treated with hepatitis C virus (HCV) ‐infected serum produce less perforin upon stimulation. CD8+ T‐cells were incubated with serum from HCV + or healthy HCV − serum for 72 hr before stimulation with anti‐CD3/28 for 48 hr. Cells were then labelled with anti‐human perforin antibody and analysed by flow cytometry. Average proportion of perforin+ cells ± SD (two‐tailed paired Student's t‐test, n = 6).

Article Snippet: Cells Human peripheral blood mononuclear cells were isolated from the blood of healthy HCV − donors using Lymphoprep (StemCell Technologies, Vancouver, BC, Canada) density gradient centrifugation, followed by isolation of CD8 + T‐cells using CD8 + T‐cell Positive Magnetic Selection Kit I or II (StemCell Technologies).

Techniques: Virus, Infection, Incubation, Flow Cytometry, Two Tailed Test